Summary Consort Medical plc (Consort Medical) is a global contract development and manufacturing organization focusing on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. The company classifies its business under two categories namely Bespak and Aesica. Bespak provides inhaler and autoinjector technologies and manufacturing services to pharmaceutical manufacturers. Aesica provides active pharmaceutical ingredient (API) and finished dose formulation and manufacturing services. The company offers its products to global pharmaceutical companies in the UK, the US, Europe, and other parts of the world through its subsidiaries and distributors. The company is headquartered in Hertfordshire, England, the UK. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: The report reviews detailed company profile with information on business description, key company facts,... Research Beam Model: Research Beam Product ID: 352248 750 USD New
Consort Medical plc (CSRT) - Product Pipeline Analysis, 2015 Update
 
 

Consort Medical plc (CSRT) - Product Pipeline Analysis, 2015 Update

  • Category : Medical Devices
  • Published On : August   2015
  • Pages : 50
  • Publisher : GlobalData
 
 
 
Summary

Consort Medical plc (Consort Medical) is a global contract development and manufacturing organization focusing on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostics. The company classifies its business under two categories namely Bespak and Aesica. Bespak provides inhaler and autoinjector technologies and manufacturing services to pharmaceutical manufacturers. Aesica provides active pharmaceutical ingredient (API) and finished dose formulation and manufacturing services. The company offers its products to global pharmaceutical companies in the UK, the US, Europe, and other parts of the world through its subsidiaries and distributors. The company is headquartered in Hertfordshire, England, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Consort Medical plc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Consort Medical plc Company Snapshot 6
Consort Medical plc Company Overview 6
Key Information 6
Consort Medical plc Pipeline Products and Clinical Trials Overview 7
Consort Medical plc – Pipeline Analysis Overview 9
Business Description 9
Key Facts 9
Consort Medical plc - Major Products and Services 10
Consort Medical plc Pipeline Products by Development Stage 11
Consort Medical plc Pipeline Products Overview 13
Bolus Drug Delivery Device 13
Bolus Drug Delivery Device Product Overview 13
DEV610 14
DEV610 Product Overview 14
INJ200 Autoinjector 15
INJ200 Autoinjector Product Overview 15
INJ570 Autoinjector 16
INJ570 Autoinjector Product Overview 16
INJ650 ASI Auto-Injector 17
INJ650 ASI Auto-Injector Product Overview 17
INJ700 Lila Mix Injector 18
INJ700 Lila Mix Injector Product Overview 18
NAS010 19
NAS010 Product Overview 19
NAS020 - Unidose Nasal Drug Delivery Device 20
NAS020 - Unidose Nasal Drug Delivery Device Product Overview 20
NAS030 21
NAS030 Product Overview 21
POC010 22
POC010 Product Overview 22
VAL020 Metered Dose Inhaler Valve 23
VAL020 Metered Dose Inhaler Valve Product Overview 23
VAL310 Easifill Valve 24
VAL310 Easifill Valve Product Overview 24
Consort Medical plc - Key Competitors 25
Consort Medical plc - Key Employees 26
Consort Medical plc - Key Employee Biographies 27
Consort Medical plc - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Consort Medical plc, Recent Developments 30
Jun 16, 2015: Consort Medical announces final results 30
Feb 23, 2015: Voke nicotine inhaler licence - variation granted by MHRA 34
Feb 11, 2015: Consort Medical Announces The Appointment Of A New Director 35
Dec 04, 2014: Consort Medical Interim Results For The Six Months Ended 31 October 2014 35
Sep 12, 2014: MHRA Authorisation of the Voke Inhaler 39
Jul 14, 2014: Consort Medical Announces Non-executive Director appointment 40
Jun 17, 2014: Consort Medical Announces Final results for the year ended 30 April 2014 40
Feb 03, 2014: FDA Approval of Development Programme 48
Nov 28, 2013: Major long-term commercial supply contract award - dry powder inhaler 49
Nov 20, 2013: Consort Medical is presenting today at the Jefferies Healthcare Conference in London 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List Of Tables
List of Tables
Consort Medical plc, Key Facts 6
Consort Medical plc Pipeline Products and Clinical Trials Overview 7
Consort Medical plc Pipeline Products by Equipment Type 7
Consort Medical plc Pipeline Products by Indication 8
Consort Medical plc, Key Facts 9
Consort Medical plc, Major Products and Services 10
Consort Medical plc Number of Pipeline Products by Development Stage 11
Consort Medical plc Pipeline Products Summary by Development Stage 12
Bolus Drug Delivery Device - Product Status 13
Bolus Drug Delivery Device - Product Description 13
DEV610 - Product Status 14
DEV610 - Product Description 14
INJ200 Autoinjector - Product Status 15
INJ200 Autoinjector - Product Description 15
INJ570 Autoinjector - Product Status 16
INJ570 Autoinjector - Product Description 16
INJ650 ASI Auto-Injector - Product Status 17
INJ650 ASI Auto-Injector - Product Description 17
INJ700 Lila Mix Injector - Product Status 18
INJ700 Lila Mix Injector - Product Description 18
NAS010 - Product Status 19
NAS010 - Product Description 19
NAS020 - Unidose Nasal Drug Delivery Device - Product Status 20
NAS020 - Unidose Nasal Drug Delivery Device - Product Description 20
NAS030 - Product Status 21
NAS030 - Product Description 21
POC010 - Product Status 22
POC010 - Product Description 22
VAL020 Metered Dose Inhaler Valve - Product Status 23
VAL020 Metered Dose Inhaler Valve - Product Description 23
VAL310 Easifill Valve - Product Status 24
VAL310 Easifill Valve - Product Description 24
Consort Medical plc, Key Employees 26
Consort Medical plc, Key Employee Biographies 27
Consort Medical plc, Other Locations 28
Consort Medical plc, Subsidiaries 29

List Of Figures
List of Figures
Consort Medical plc Pipeline Products by Equipment Type 8
Consort Medical plc Pipeline Products by Development Stage 11
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter